CLOV vs REFR
Clover Health Investments Corp (CLOV) versus Research Frontiers Incorporated (REFR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Research Frontiers Incorporated (REFR) is a electronic components company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported REFR revenue for 2024-12-31 was $1.3M. Net income was -$1.3M. Revenue was up 46.8% from 2023-12-31 to 2024-12-31. REFR currently screens at market cap $22.4M.
CLOV currently screens at market cap $1.55B. REFR currently screens at market cap $22.4M.
Not investment advice. Open the CLOV and REFR stock pages for the full models.
Not investment advice.